Tomas Jelinek (Tomas Jelínek, Tomáš Jelínek)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 29

Top Venues

International journal of molecular sciences

British journal of haematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood advances

Clinica Universitaria de Navarra

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Clinica Universitaria de Navarra Jan 1o 2016

Spain

researcher/physician :: Department of Haematology / Centro de Investigacion Medica Aplicada (CIMA)

Publications

Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Spicka
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies. Blood cancer journal 13 (1) (2023)
Marcello Turi, Anjana Anilkumar Sithara, Lucie Hofmanová, David Žihala, Dhwani Radhakrishnan, Alexander Vdovin, Sofija Knápková, Tereza Ševčíková, Zuzana Chyra, Tomas Jelinek, Michal Simicek, Annamaria Gullà, Kenneth Carl Anderson, Roman Hájek, Matous Hrdinka
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling. International journal of molecular sciences 24 (6) (2023)
Marcello Turi, Anjana Anilkumar Sithara, Lucie Hofmanová, David Žihala, Dhwani Radhakrishnan, Alexander Vdovin, Sofija Knápková, Tereza Ševčíková, Zuzana Chyra, Tomas Jelinek, Michal Simicek, Annamaria Gullà, Kenneth Carl Anderson, Roman Hájek, Matous Hrdinka
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling. International journal of molecular sciences 24 (6) (2023)
Ondrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, David Zihala, Ludmila Muronova, Tereza Sevcikova, Jan Vrana, Alexander Vdovin, Jakub Radocha, Petra Krhovska, Matous Hrdinka, Michal Turjap, Tereza Popkova, Zuzana Chyra, Lucie Broskevicova, Michal Simicek, Zdenek Koristek, Roman Hájek, Tomas Jelinek
Insight into the mechanism of CD34 + cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy. British journal of haematology (2023)
Marcello Turi, Anjana Anilkumar Sithara, Lucie Hofmanová, David Žihala, Dhwani Radhakrishnan, Alexander Vdovin, Sofija Knápková, Tereza Ševčíková, Zuzana Chyra, Tomas Jelinek, Michal Simicek, Annamaria Gullà, Kenneth Carl Anderson, Roman Hájek, Matous Hrdinka
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling. International journal of molecular sciences 24 (6) (2023)
Hana Sahinbegovic, Alexander Vdovin, Renata Snaurova, Michal Durech, Jakub Nezval, Jiri Sobotka, Roman Hajek, Tomas Jelinek, Michal Simicek
Length-Dependent Translation Efficiency of ER-Destined Proteins. Current issues in molecular biology 45 (8) (2023)
Leire Burgos, Luis-Esteban Tamariz-Amador, Noemi Puig, María-Teresa Cedena, Camilla Guerrero, Tomas Jelinek, Sarah Johnson, Paolo Milani, Lourdes Cordon, Jose J Perez, Marta Lasa, Rosalinda Termini, Albert Ortiol, Miguel-Teodoro T Hernandez Garcia, Luis Palomera, Rafael Martinez-Martinez, Javier de la Rubia, Felipe de Arriba, Rafael Rios-Tamayo, Maria-Esther Gonzalez, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Isabel Krsnik, Albert Perez-Montaña, Verónica González De La Calle, Paula Rodriguez-Otero, Vladimir Maisnar, Roman Hájek, Frits van Rhee, Victor Jimenez-Zepeda, Giovanni Palladini, Giampaolo Merlini, Alberto Orfao, Javier de la Cruz, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, null null
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martín-Sánchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis-Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Martin Stork, Sabina Sevcikova, Tomas Jelinek, Jiří Minařík, Jakub Radocha, Tomas Pika, Lenka Pospisilova, Ivan Spicka, Jan Straub, Petr Pavlicek, Alexandra Jungova, Zdenka Knechtova, Viera Sandecka, Vladimir Maisnar, Roman Hajek, Ludek Pour
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas. Biomedicines 10 (10) (2022)
Monika Vlachová, Jana Gregorová, Petra Vychytilova-Faltejskova, Natalia Anna Gabło, Lenka Radová, Lenka Pospíšilová, Martina Almáši, Martin Stork, Zdeňka Knechtová, Jiří Minařík, Tereza Popková, Tomas Jelinek, Roman Hájek, Luděk Pour, Lucie Říhová, Sabina Sevcikova
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma. International journal of molecular sciences 23 (23) (2022)
Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Ševčíková, Anjana Anilkumar Sithara, Lenka Pospisilova, Sabina Sevcikova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Veronika Kapustová, Tereza Popkova, Ludmila Muronova, Zuzana Chyra, Matous Hrdinka, Michal Simicek, Juan-José Garcés, Noemi Puig, María-Teresa Cedena, Artur Jurczyszyn, Jorge J Castillo, Miroslav Penka, Jakub Radocha, Maria-Victoria Mateos-Manteca, Jesús San F Miguel, Juan José Lahuerta, Ludek Pour, Lucie Říhová, Roman Hájek
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jiří Minařík, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Tomas Pika, Ludek Pour, Petr Pavlicek, Lubica Harvanova, Lenka Pospisilova, Petra Krhovska, Denisa Novakova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Vladimir Maisnar, Roman Hajek
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy. Cancers 14 (20) (2022)
Cirino Botta, Catarina Da Silva Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, Maria-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan M Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo M Roccaro, Hartmut Goldschmidt, Herve Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Juan José Lahuerta
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology. Blood advances (2021)
Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Říhová, Renata Bezdekova, David Zihala, Kateřina Growková, Jana Filipova, Lucie Černá, Lucie Broskevičová, Fedor Kryukov, Jiří Minařík, Jana Smejkalová, Vladimir Maisnar, Lubica Harvanová, Ludek Pour, Alexandra Jungova, Tereza Popkova, Juli Rodriguez Bago, Anjana Anilkumar Sithara, Matous Hrdinka, Tomas Jelinek, Michal Simicek, Giovanni Stracquadanio, Roman Hajek
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine. Blood advances (2021)
Tomas Jelinek, Tereza Sevcikova, David Zihala, Tereza Popkova, Veronika Kapustova, Lucie Broskevicova, Lenka Capkova, Lucie Rihova, Renata Bezdekova, Sabina Sevcikova, Vladimir Zidlik, Martin Havel, Hana Plonkova, Alexandra Jungova, Jiri Minarik, Martin Stork, Ludek Pour, Petr Pavlicek, Ivan Spicka, Vladimir Maisnar, Jakub Radocha, Michal Simicek, Roman Hájek
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease. Leukemia (2021)
Renata Bezděková, Tomas Jelinek, Romana Kralova, Martin Stork, Petra Polackova, Pavla Vsianska, Lucie Brozova, Jiri Jarkovsky, Martina Almasi, Ivanna Boichuk, Zdenka Knechtova, Miroslav Penka, Ludek Pour, Sabina Sevcikova, Roman Hájek, Lucie Říhová
Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia. British journal of haematology 195 (1) (2021)
Jana Mihályová, Katarína Hradská, Tomas Jelinek, Benjamin Motais, Piotr Celichowski, Roman Hájek
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders. International journal of molecular sciences 22 (21) (2021)
Tomas Jelinek, Tereza Popkova, Juraj Duras, Jana Mihalyova, Michal Kascak, Katerina Benkova, Hana Plonkova, Lucie Cerna, Zdenek Koristek, Michal Simicek, Roman Hajek
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort. Hematological oncology 38 (3) (2020)
Katarina Hradska, Michal Kascak, Roman Hajek, Tomas Jelinek
Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma. Expert review of hematology 13 (4) (2020)
Hana Sahinbegovic, Tomas Jelinek, Matous Hrdinka, Juli R Bago, Marcello Turi, Tereza Sevcikova, Amina Kurtovic-Kozaric, Roman Hajek, Michal Simicek
Intercellular Mitochondrial Transfer in the Tumor Microenvironment. Cancers 12 (7) (2020)
Ivo Demel, Julio Rodriguez Bago, Roman Hájek, Tomas Jelinek
Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021. British journal of haematology 193 (4) (2020)
Tereza Popkova, Roman Hájek, Tomas Jelinek
Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits. British journal of haematology 189 (2) (2020)
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant D Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Efstathios Kastritis, Robin Aitchison, Meletios- Athanasios Dimopoulos, Athanasios Zomas, Roman Hájek
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Annals of hematology 99 (5) (2020)
Tomas Jelinek, Jana Mihalyova, Michal Kascak, Juraj Duras, Tereza Popkova, Katerina Benkova, Petra Richterova, Hana Plonkova, Jana Zuchnicka, Lucie Broskevicova, Lucie Huvarova, Lucie Cerna, Katerina Growkova, Michal Simicek, Martin Havel, Jaromir Gumulec, Milan Navratil, Zdenek Koristek, Bruno Paiva, Roman Hajek
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14). American journal of hematology 94 (1) (2018)
Tomas Jelinek, Jana Mihalyova, Michal Kascak, Juraj Duras, Roman Hajek
PD-1/PD-L1 inhibitors in haematological malignancies: update 2017. Immunology 152 (3) (2017)

Tomas Jelinek.css-eqlu8i{font-size:small;padding-left:4px;} (Tomas Jelínek, Tomáš Jelínek)

Publication Activity (10 Years)

Top Topics

Top Venues

Tomas Jelinek (Tomas Jelínek, Tomáš Jelínek)